Navigation Links
Elekta Negotiates To Acquire CMS
Date:1/8/2008

peline of advanced functionality in development, could significantly contribute to our MOSAIQ RTP strategy going forward. CMS's large, highly competent product creation and support organizations would enable us to accelerate our development and bring these solutions to our customers more quickly and effectively."

"At CMS, we are excited about the opportunity of joining the Elekta Group and are fully committed to the timely completion of all necessary steps in the transaction. Combined, Elekta and CMS will strengthen its market position and the transformation of CMS into a center of excellence in treatment planning technology will be of great value for the combined organization and our customers," comments Andrew C. Cowen, President and CEO of CMS.

Financial effects of the transaction

CMS is based in St Louis, Missouri and is owned by a private equity fund, managed by the US investment bank Brown Brothers Harriman. The company has 290 employees worldwide. In fiscal year 2007 (ending September), the company grew its order intake by 21 percent to USD 61 M.

Management expects a successful completion of the acquisition process to result in:

-- Accretion to earnings on a cash basis already from fiscal year 2008/09

-- Mildly dilution to reported earnings in fiscal year 2008/09 as a

result of expected amortization of intangibles associated with the

acquisition and 'fair value' adjustments of certain balance sheet

items under IFRS accounting standards

-- Accelerated revenue growth, but with modest group effect given the

size of the acquired business

-- Preserved balance sheet strength and financial flexibility

About CMS

CMS is a worldwide leader in the development and support of radiation treatment planning and workflow management solutions. With treatment planning systems installed in more than 1,500 sites worldwide, CMS is a global resource to the radiation
'/>"/>

SOURCE Elekta, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Elekta Showcases Stereotactic Systems for Cancer Care at Astro 2007
2. Beaumont Hospital, Royal Oak Treats Its First Patients With Elekta Axesse
3. Elekta Announces Elekta Infinity - a New System for Faster and More Precise Treatment of Cancer Tumors
4. Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007
5. Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO
6. Elekta Brings Intelligent Ways to Manage Motion During Cancer Treatment to ESTRO
7. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
8. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
9. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
10. Elekta Demonstrates Commitment to Stereotactic Innovation at EANS
11. Johns Hopkins to add Elekta Synergy S(R) to Cancer Treatment Lineup
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 29, 2015  AsureQuality and Ubiquitome have agreed ... applications in food and primary production sectors. The ... PCR device, the Freedom4. AsureQuality provides ... the supermarket shelf for producers, processors and Competent ... animal disease control and pest management and surveillance ...
(Date:7/29/2015)... Research and Markets ... the "Global Biosimilars Market, 2015 - 2025" ... Global Biosimilars Market, 2015 - 2025, report provides ... market. With the blockbuster biologics losing patent protection ... are being viewed as viable substitutes to the ...
(Date:7/29/2015)... , July 29, 2015  AmnioChor Inc., an early ... is very pleased to announce that the Musculoskeletal Transplant ... agreed to invest in their seed round of development ... tissue storage capabilities. AmnioChor,s technology allows ... the human stem cells living within those tissues. Amnion ...
(Date:7/29/2015)... , July 29, 2015  Pfenex Inc. (NYSE ... financial results will be released on Thursday, August 13, ... Eastern Time, Pfenex management will host a conference call ... update.  A press release outlining the financial results and ... call. Please call 1-866-376-8058 (US) or 1-412-542-4131 ...
Breaking Biology Technology:AsureQuality and Ubiquitome Partner on Applications for Mobile Molecular Food Safety Testing 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 2Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2
... Inc. (NYSE: BMR ), a real estate investment trust ... announced financial results for the third quarter ended September 30, 2010. ... record total revenues for the third quarter of $95.7 million, up ... Increased rental revenues for the third quarter by 6.6% to a ...
... UPTON, NY - Scientists at the U.S. Department of ... Laboratory have fabricated transparent thin films capable of absorbing ... area. The material, described in the journal Chemistry ... solar panels or even windows that absorb solar energy ...
... 2010 Bolder BioTechnology, Inc. today announced that it ... Qualifying Therapeutic Discovery Project Grants.  Grants were awarded for ... Credit Program, which authorized up to $1 billion in ... or fewer employees.   The Qualifying Therapeutic ...
Cached Biology Technology:BioMed Realty Trust Reports Third Quarter 2010 Financial Results 2BioMed Realty Trust Reports Third Quarter 2010 Financial Results 3BioMed Realty Trust Reports Third Quarter 2010 Financial Results 4BioMed Realty Trust Reports Third Quarter 2010 Financial Results 5BioMed Realty Trust Reports Third Quarter 2010 Financial Results 6BioMed Realty Trust Reports Third Quarter 2010 Financial Results 7BioMed Realty Trust Reports Third Quarter 2010 Financial Results 8BioMed Realty Trust Reports Third Quarter 2010 Financial Results 9BioMed Realty Trust Reports Third Quarter 2010 Financial Results 10BioMed Realty Trust Reports Third Quarter 2010 Financial Results 11BioMed Realty Trust Reports Third Quarter 2010 Financial Results 12BioMed Realty Trust Reports Third Quarter 2010 Financial Results 13BioMed Realty Trust Reports Third Quarter 2010 Financial Results 14BioMed Realty Trust Reports Third Quarter 2010 Financial Results 15BioMed Realty Trust Reports Third Quarter 2010 Financial Results 16BioMed Realty Trust Reports Third Quarter 2010 Financial Results 17Transparent conductive material could lead to power-generating windows 2Bolder BioTechnology Announces $1.2 Million in Qualifying Therapeutic Discovery Project Grants 2
(Date:7/23/2015)... Aware, Inc. (NASDAQ: AWRE ), a leading supplier of ... second quarter ended June 30, 2015.  Revenue ... decrease of 33% compared to $6.8 million in the same ... 2015 was $0.3 million, or $0.01 per diluted share, which ... the same period a year ago.  Lower ...
(Date:7/21/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market and ... it has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology ... but also the user using unique personal identifiers ...
(Date:7/13/2015)... SAN JOSE, Calif. , July 13, 2015 ... the leading developer of human interface solutions, today ... second generation touch and display driver integration (TDDI) ... solution is the first to combine Synaptics , ... expertise with proven display driver technology developed in ...
Breaking Biology News(10 mins):Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3
... research experiment in Kathmandu, Nepal, this month using advanced ... environmental health scientist Rick Peltier at the University of ... in a real-world setting that air pollution can and ... simply on the volume of particles in the air. ...
... emergence of MRSA ( Staphylococcus aureus ), dubbed a ... has resulted in the glycopeptide antibiotic Vancomycin being commonly ... to drugs has led to concerns of a ,creeping ... treat infection. In adults, nomograms are used to calculate ...
... VEGAS , Jan. 7, 2014 from ShowStoppers @ ... of securing consumer data on mobile and other digital devices, ... data once it leaves the device and enters the cloud. ... announced the formalization of its Biometric Open Standards Protocols (BOPS). ...
Cached Biology News:Updating air pollution measurement methods with air quality, health effects research 2Updating air pollution measurement methods with air quality, health effects research 3Hoyos Labs Issues Biometric Open Protocol Standard for Safer Authentication 2Hoyos Labs Issues Biometric Open Protocol Standard for Safer Authentication 3
Carrier Serum...
A Highly Purified, Cost-Effective Taq DNA Polymerase...
Homo sapiens similar to Cytosolic acyl coenzyme A thioester hydrolase Antigen: Peptide...
... RNase Inhibitor (patent pending) is a protein ... binds and inhibits the most common and ... 1 and T1. SUPERaseIn can be used ... be problematic. It is ideal for in ...
Biology Products: